Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-240520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Che-Yuan Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Dementia, Phosphodiesterase 5 Inhibitors. Die Arbeit nennt 13 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Pharmacoepidemiologic studies using routinely collected data allow researchers to propose drugs for repurposing trials for dementia prevention or treatment. A recent cohort study reported a 54% lower dementia risk among users of sildenafil compared to users of certain cardiovascular medications. We caution that “confounding by indication” can arise when outcomes are compared between a drug of interest and an inappropriate comparator. Here, we emphasize important considerations in selecting an active comparator. We assess the implications of substantial risk of confounding by indication in pharmacoepidemiologic studies linking phosphodiesterase-5 inhibitors to lower dementia risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
- Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Zitieren
APA
Wu, C. Y., & Swardfager, W. (2024). Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240520
Vancouver
Wu CY, Swardfager W. Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240520
BibTeX
@article{Wu2024,
author = {Wu, Che-Yuan and Swardfager, Walter},
title = {Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-240520}
}
EUVIMED